India Cancer Pain Management Market Report 2022 to 2030

India Cancer Pain Management Market Analysis

$ 3999

India's Cancer Pain Management market is projected to grow from $118.57 Mn in 2022 to $224.39 Mn by 2030, registering a CAGR of 8.3% during the forecast period of 2022 - 2030. The main factors driving the growth would be government initiatives, increasing private sector investment, rising incidence of cancer, and technological advances. The market is segmented by drug type and by disease. Some of the major players include Accord Healthcare (IND), Dr. Reddy’s (IND), Pfizer, Abbott, and Teva Pharmaceuticals.

ID: IN10INHS002 CATEGORY: Healthcare Services GEOGRAPHY: India AUTHOR: Neha Davda

Buy Now

India Cancer Pain Management Market Executive Summary

India's Cancer Pain Management market is projected to grow from $118.57 Mn in 2022 to $224.39 Mn by 2030, registering a CAGR of 8.3% during the forecast period of 2022 - 2030. Over the past ten years, India's health spending has steadily increased in order to support its growing population. From 2.95% of GDP in 2018, health spending rose to 3.01% in 2019. India still spends less on healthcare than most developed countries, notwithstanding recent advances. The government is making an effort to enhance the healthcare system by increasing public spending on healthcare and implementing reform measures, but there are still numerous challenges to be solved.

Cancer pain can result from the disease itself or from treatments like chemotherapy and surgery that are performed in conjunction with it. The type, location, and degree of pain felt have an impact on the medication choice and use. For the treatment of cancer pain, various drugs are employed. For instance, when treating mild to moderate cancer pain, powerful opioids such as acetaminophen and NSAIDs are preferred over non-opioids such as these. The cancer pain management market in India is a rapidly growing market in Asia-Pacific.

india cancer pain management market analysis

Market Dynamics

Market Growth Drivers

The Indian cancer pain management market is expected to be driven by factors such as government initiatives, rising incidence of cancer, and technological advances. Moreover, the private sector is increasing its investments in India's healthcare industry, which includes the market for cancer pain management.

Market Restraints

A number of challenges with India's healthcare system, such as a lack of infrastructure, inadequate financing, and limited access to healthcare services along with the adverse side effects of pain management drugs, would restrain the market's expansion for cancer pain management in India.

Competitive Landscape

Key Players

Accord Healthcare (IND)
Dr. Reddy’s Laboratories (IND)
Pfizer
Abbott
Teva Pharmaceuticals

Notable Recent Deals

January 2023: Dr. Reddy’s Laboratories acquired the trademark rights for the breast cancer medication PRIMCYV from Pfizer Products India Pvt Ltd. for usage in the Indian market. PRIMCYV is a targeted medication with the active ingredient palbociclib, a first-in-class CDK 4/6 inhibitor recommended in conjunction with an aromatase inhibitor for the first-line treatment of adult patients with HR+, HER2-metastatic breast cancer.

Healthcare Policies and Regulatory Landscape

The Central Drugs Standard Control Organization (CDSCO) and the Ministry of Health and Family Welfare primarily oversee the regulatory framework for pain management in India's healthcare system. In India, pharmaceuticals, including items for pain management, are produced, distributed, and sold under the control of the CDSCO.

In addition to the CDSCO, there are additional regulatory organizations, such as the National Pharmaceutical Pricing Authority (NPPA), which determines the costs of important medications in India, such as painkillers. Additionally, the government maintains a National List of Important Medicines (NLEM), which is a list of affordable medications that are deemed essential for the general public.

Reimbursement Scenario

As per the type of treatment, the patient's insurance coverage, and the accessibility of government financing, the reimbursement scenario for the pain management market in India differs. Reimbursement for pain management treatments is typically available to those with private insurance, though the coverage and level of reimbursement may differ depending on the insurance company. Treatments for pain management are also reimbursable for people who are protected by government health insurance plans like the Pradhan Mantri Jan Arogya Yojana (PMJAY).

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cancer Pain Management Market Segmentation

By Drug Type (Revenue, USD Billion):

Non-steroidal anti-inflammatory medicines relieve pain at the site of injury by blocking the cyclooxygenase enzyme, which prevents prostaglandin formation. NSAIDs are a class of medications that includes medications with analgesic, antipyretic, and, at higher doses, anti-inflammatory properties.

Opioids
Morphine
- Fentanyl
- Others
Non-Opioids
Acetaminophen
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Nerve Blockers

By Disease Indication (Revenue, USD Billion):

Based on disease Indication the market is segmented into:

Lung Cancer
Colorectal cancer
Breast cancer
Prostate cancer
Blood cancer
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.